InvestorsHub Logo
Followers 67
Posts 1293
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Wednesday, 06/15/2022 12:16:00 PM

Wednesday, June 15, 2022 12:16:00 PM

Post# of 700280
To the board: Think a bit more rationally out of box. We are much more than whether or when a publication of trial results will come or in which prestigious journal will the results be published, because that's not the point.

Making no mistake, the results will be published in a first-tier medical journal. If you have not realized this, you cannot be taught!

There is definitely something more than just a publication, and of course it's the approval of RAs, particularly FDA. To that end, Linda has put the whole management team into an endless quiet period, and when things are settled, it may show it's an indeed a wise decision for all parties involved.

So "forget" publication because it's a convenient and strategic thing up to this point.

So it's absolutely possible a RA approval may come earlier than the publication, or come simultaneously or a short time spaced.

The most important thing which the company has pursued so far is regulatory whisper.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News